The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.
December 14th 2024
Emerging research in triple-negative breast cancer highlights the promise of molecular-based approaches to improve treatment outcomes.
Precision Oncology: Expanding Therapeutic Horizons With Trastuzumab Deruxtecan
December 3rd 2024The tumor-agnostic FDA approval of T-DXd for HER2-positive unresectable or metastatic solid malignancies exemplifies the importance of understanding the risks associated with targeted therapy and the need for proactive monitoring strategies.
Read More
Social Determinants of Health Matter When Treating Patients With Breast Cancer
Pharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.
Read More
Dato-DXd Did Not Achieve Statistically Significant OS in Patients With Breast Cancer
September 24th 2024Compared with chemotherapy, datopotamab deruxtecan (Dato-DXd) did not achieve a statistically significant overall survival (OS) in patients with inoperable or metastatic HR+/HER2-low or negative breast cancer.
Read More